Global Anti-Infectives Market to Grow at a CAGR of 4.3% During 2024-2032, Driven by the Growing Presence of an Extensive Distribution Channel

The global market for anti-infectives is being driven by the increasing awareness among consumers through print or digital media, including television advertisements, regarding the avoidable risks associated with early treatment of infectious diseases. With the presence of an extensive distribution channel, the easy availability of anti-infective tablets, powders, ointments, and creams is invigorating the growth of the market. Further, the distribution channels, such as retail pharmacies and speciality pharmacies are generally found in every neighbourhood, which usually have topical anti-infectives at considerable prices. This is another factor contributing to the growth of the market. Furthermore, the age of digitisation and the flourishing e-commerce industry has led to the development of online pharmacies, which aid in quick deliveries at discounted prices, thereby adding to the market growth of anti-infectives.

AirCuris Anti-Infective Cures AG, a significant company in the global market for anti-infectives, recently revealed the opening of the 2nd round of its AiCubator corporate innovation accelerator initiative in October 2021. The AiCubator is engineered to help scientists and startup companies foster innovation in the anti-infectives and to encourage ideas that might lead to the development of advanced anti-infectives. The core of the project is on targeted antiviral therapies for hepatitis B virus cure, Epstein-Barr virus, BK virus,  and adenovirus as well as antibacterial therapy for bloodstream and diabetic foot infections. As a leading company in the discovery and development of drugs against infectious diseases, AiCuris provides a platform for the development of effective medicines. Such developments by leading market players are invigorating the growth of the market. The market is further expected to be propelled by the expansion of market leaders like Pfizer Inc. (NYSE: PFE).

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Type, Route of Administration, Distribution Channel, and Region:

• On the basis of type, the market can be divided into antibacterial, antifungal, and antiviral.

• Based on route of administration, the market can be categorised into topical, oral, and intravenous (IV), among others.

• The market, based on distribution channel, can be fragmented into hospital pharmacy, retail pharmacy, speciality pharmacy, and online, among others.

• The major regional markets for the product include North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa.

Key Findings of the Report:

• The rise in the global market for anti-infectives can be determined by the increasing prevalence of infectious diseases owing to unhygienic lifestyles, lack of proper sanitation, and unclean environments.

• Rising awareness regarding the avoidable risks associated with early treatment of infectious diseases with anti-infectives is invigorating the growth of the market.

• Easy availability of anti-infectives in the form of ointments, creams, powders, and tablets through an extensive distribution channel, including online and offline, is driving the growth of the market.

• The flourishing pharmaceutical industries owing to robust investments to develop an effective treatment against infectious diseases, is propelling the market growth.

Key Offerings of the Report:

• The EMR report gives an overview of the global anti-infectives industry for the periods (2018-2023) and (2024-2032).

• The report also offers historical (2018-2023) and forecast (2024-2032) markets for types, routes of administration, distribution channels, and major regions of anti-infectives.

• The report analyses market dynamics, covering the key demand and price indicators in the market along with an assessment of the SWOT and Porter’s Five Forces Model.

The major players in the global anti-infectives market are Gilead Sciences, Inc., Sandoz International GmbH, Pfizer Inc., GlaxoSmithKline plc., and Abbott Laboratories, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.